Risk-Based Full Factorial Design — Risk-Informed Experimental Planning
Risk-Based Full Factorial Design of Experiments · Also known as: risk-informed full factorial design, RB-FFD, risk-prioritized factorial experiment, risk-based FFD
Risk-based full factorial design integrates formal risk analysis — typically Failure Mode and Effects Analysis (FMEA) or a comparable risk-ranking tool — with a full factorial experiment to ensure that factors posing the greatest quality or safety risk receive exhaustive experimental coverage. All combinations of selected factor levels are run, but the selection of which factors to include and the range of their levels is explicitly guided by prior risk scores rather than purely by engineering intuition or resource availability.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use risk-based full factorial design when regulatory, safety, or quality requirements demand exhaustive, defensible evidence about interactions among the most critical process or formulation factors, and when a prior risk assessment has successfully narrowed the candidate factor list to a manageable number (typically k ≤ 5 for a full factorial at two levels). It is the method of choice in pharmaceutical Quality by Design (QbD), medical device development, and high-consequence engineering contexts where missing a risk-critical interaction is unacceptable. Do not use it when no prior risk information is available (a standard screening design is more appropriate), when the number of risk-critical factors exceeds five or six (the run count becomes prohibitive; use a fractional factorial or response surface design instead), or when all factors are low-risk (a simpler one-factor-at-a-time or screening approach suffices).
Strengths & limitations
- Provides complete, unconfounded estimation of all main effects and interactions among risk-critical factors, leaving no scientifically critical combination untested.
- Aligns experimental effort with regulatory and business risk priorities, making resource use defensible to auditors and stakeholders.
- The integrated risk-update step creates a documented, traceable link between experimental evidence and the living risk register.
- Particularly well-supported by ICH Q8/Q9/Q10 guidelines, making it the standard framework for pharmaceutical QbD submissions.
- Full factorial structure means no assumptions about effect sparsity are required — all interactions are observed directly.
- Run count grows exponentially: k = 5 two-level factors requires 32 runs, k = 6 requires 64; beyond that, resource constraints make a full factorial impractical.
- Depends heavily on the quality of the upstream risk assessment — poor FMEA scores may exclude genuinely important factors or include irrelevant ones.
- Only factors within the selected set are fully characterized; interactions involving excluded low-risk factors remain unexamined.
- Not suited to continuous factor optimization over a broad space — response surface methods (CCD, Box-Behnken) serve that purpose better.
Frequently asked
How is risk-based full factorial design different from a standard full factorial design?
A standard full factorial design selects factors based on engineering judgment or prior knowledge alone. Risk-based full factorial design adds a formal upstream risk assessment — such as FMEA — that scores every candidate factor by severity, occurrence, and detectability. Only factors exceeding a defined risk threshold are included in the experiment, and the results feed back into the risk register. The experimental structure is identical; the difference lies in the principled, documented basis for factor selection and the two-way integration with risk management.
What risk assessment tool should I use before the experiment?
FMEA is the most common choice and is explicitly referenced in ICH Q9 and many regulatory guidance documents. Alternatives include risk matrices (likelihood vs. severity grids), Ishikawa (fishbone) analysis combined with expert scoring, or quantitative risk indices. The key requirement is that every candidate factor receives a traceable, documented score so that inclusion and exclusion decisions can be defended to auditors.
What if too many factors exceed the risk threshold?
If more than five or six factors are classified as risk-critical, a full factorial becomes impractical. Options include: (1) applying a fractional factorial design that maintains resolution IV or V to preserve interaction estimability for the most critical pairs; (2) running a Plackett-Burman or other screening design first to empirically reduce the factor list; or (3) re-examining the risk threshold with subject-matter experts to distinguish truly critical from moderately important factors.
Is this approach required by regulators?
For pharmaceutical QbD submissions under ICH Q8(R2), risk-informed experimental design is strongly encouraged and in practice expected by agencies such as the FDA and EMA. For medical devices, ISO 14971 (risk management) and relevant validation standards create a similar expectation. In other industries it is best practice rather than a regulatory mandate, but the documented rationale it provides is increasingly valued in audits and supplier qualification reviews.
How do I handle factors I excluded from the experiment?
Low-risk factors should be held at their nominal (target) operating values throughout the experiment and documented as such. The risk register should record the justification for exclusion. If process conditions shift such that a previously low-risk factor moves into a higher-risk range, the risk assessment should be repeated and the experimental design revisited.
Sources
- Montgomery, D. C. (2017). Design and Analysis of Experiments (9th ed.). Wiley. ISBN: 978-1119113478
- International Council for Harmonisation. (2009). ICH Q8(R2): Pharmaceutical Development — Quality by Design and Risk-Based Experimental Approaches. ICH Secretariat. link ↗
How to cite this page
ScholarGate. (2026, June 3). Risk-Based Full Factorial Design of Experiments. ScholarGate. https://scholargate.app/en/experimental-design/risk-based-full-factorial-design
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Design of experimentsExperimental design↔ compare
- Failure Mode and Effects AnalysisExperimental design↔ compare
- Robust Full Factorial DesignExperimental design↔ compare